Vanguard PRIMECAP Core Fund Investor Shares (VPCCX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
35.04
+0.02 (0.06%)
May 17, 2024, 4:00 PM EDT
19.79% (1Y)
Fund Assets | 12.62B |
Expense Ratio | 0.46% |
Min. Investment | $3,000 |
Turnover | 6.00% |
Dividend (ttm) | 1.82 |
Dividend Yield | 5.19% |
Dividend Growth | -20.40% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 19, 2023 |
Previous Close | 35.02 |
YTD Return | 10.40% |
1-Year Return | 27.75% |
5-Year Return | 91.96% |
52-Week Low | 28.61 |
52-Week High | 35.24 |
Beta (5Y) | 0.92 |
Holdings | 173 |
Inception Date | Dec 9, 2004 |
About VPCCX
The fund invests in stocks that its advisor believes offer a good balance between reasonable valuations and attractive growth prospects relative to their peers. Stocks selected for the fund typically have earnings growth potential that, in the advisor's view, is not reflected in their current market prices. It can invest in stocks across all industry sectors and market capitalizations.
Fund Family Vanguard
Category Large Blend
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol VPCCX
Index MSCI US Prime Market 750 TR
Performance
VPCCX had a total return of 27.75% in the past year. Since the fund's inception, the average annual return has been 6.66%, including dividends.
Top 10 Holdings
35.02% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 10.59% |
Mktliq 12/31/2049 | n/a | 3.56% |
Microsoft Corporation | MSFT | 3.17% |
KLA Corporation | KLAC | 2.94% |
Amgen Inc. | AMGN | 2.92% |
AstraZeneca PLC | AZN | 2.88% |
Intel Corporation | INTC | 2.65% |
Siemens AG | SIE.DE | 2.14% |
Biogen Inc. | BIIB | 2.13% |
FedEx Corporation | FDX | 2.05% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 19, 2023 | $1.8173 | Dec 20, 2023 |
Dec 19, 2022 | $2.283 | Dec 20, 2022 |
Dec 20, 2021 | $2.3178 | Dec 21, 2021 |
Dec 21, 2020 | $2.2879 | Dec 22, 2020 |
Dec 17, 2019 | $1.9508 | Dec 18, 2019 |
Dec 18, 2018 | $2.2107 | Dec 19, 2018 |